nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—SLC15A2—choroid plexus—germ cell cancer	0.0611	0.568	CbGeAlD
Ceftibuten—Nephropathy toxic—Bleomycin—germ cell cancer	0.0239	0.0267	CcSEcCtD
Ceftibuten—Nephropathy toxic—Ifosfamide—germ cell cancer	0.0204	0.0229	CcSEcCtD
Ceftibuten—Nephropathy toxic—Cisplatin—germ cell cancer	0.0176	0.0197	CcSEcCtD
Ceftibuten—Nephropathy toxic—Etoposide—germ cell cancer	0.0161	0.0181	CcSEcCtD
Ceftibuten—Cholestasis—Ifosfamide—germ cell cancer	0.0154	0.0173	CcSEcCtD
Ceftibuten—Aplastic anaemia—Dactinomycin—germ cell cancer	0.012	0.0135	CcSEcCtD
Ceftibuten—Rigors—Etoposide—germ cell cancer	0.0113	0.0127	CcSEcCtD
Ceftibuten—Pancytopenia—Vinblastine—germ cell cancer	0.00967	0.0108	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00942	0.0106	CcSEcCtD
Ceftibuten—Renal impairment—Ifosfamide—germ cell cancer	0.00894	0.01	CcSEcCtD
Ceftibuten—Candida infection—Etoposide—germ cell cancer	0.00883	0.0099	CcSEcCtD
Ceftibuten—Aphasia—Methotrexate—germ cell cancer	0.00854	0.00958	CcSEcCtD
Ceftibuten—Agranulocytosis—Vinblastine—germ cell cancer	0.00847	0.00949	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00836	0.00936	CcSEcCtD
Ceftibuten—Psychotic disorder—Ifosfamide—germ cell cancer	0.00831	0.00931	CcSEcCtD
Ceftibuten—Haemoglobin—Vinblastine—germ cell cancer	0.00819	0.00918	CcSEcCtD
Ceftibuten—Pancytopenia—Bleomycin—germ cell cancer	0.00817	0.00915	CcSEcCtD
Ceftibuten—Haemorrhage—Vinblastine—germ cell cancer	0.00815	0.00913	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00812	0.0091	CcSEcCtD
Ceftibuten—Nasal congestion—Cisplatin—germ cell cancer	0.00805	0.00902	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00766	0.00858	CcSEcCtD
Ceftibuten—Pancytopenia—Dactinomycin—germ cell cancer	0.00762	0.00854	CcSEcCtD
Ceftibuten—Neutropenia—Dactinomycin—germ cell cancer	0.0075	0.0084	CcSEcCtD
Ceftibuten—Haematuria—Bleomycin—germ cell cancer	0.00731	0.00819	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00709	0.00794	CcSEcCtD
Ceftibuten—Irritability—Cisplatin—germ cell cancer	0.007	0.00784	CcSEcCtD
Ceftibuten—Pancytopenia—Ifosfamide—germ cell cancer	0.00698	0.00782	CcSEcCtD
Ceftibuten—Haemoglobin—Bleomycin—germ cell cancer	0.00692	0.00775	CcSEcCtD
Ceftibuten—Haemorrhage—Bleomycin—germ cell cancer	0.00688	0.00771	CcSEcCtD
Ceftibuten—Dysuria—Ifosfamide—germ cell cancer	0.00687	0.0077	CcSEcCtD
Ceftibuten—Dehydration—Cisplatin—germ cell cancer	0.00682	0.00764	CcSEcCtD
Ceftibuten—Agranulocytosis—Dactinomycin—germ cell cancer	0.00667	0.00748	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.0065	0.00728	CcSEcCtD
Ceftibuten—Renal failure—Ifosfamide—germ cell cancer	0.00644	0.00722	CcSEcCtD
Ceftibuten—Haematuria—Ifosfamide—germ cell cancer	0.00625	0.007	CcSEcCtD
Ceftibuten—Chills—Bleomycin—germ cell cancer	0.00618	0.00692	CcSEcCtD
Ceftibuten—Convulsion—Vinblastine—germ cell cancer	0.00615	0.00689	CcSEcCtD
Ceftibuten—Agranulocytosis—Ifosfamide—germ cell cancer	0.00612	0.00685	CcSEcCtD
Ceftibuten—Erythema multiforme—Dactinomycin—germ cell cancer	0.00607	0.0068	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00605	0.00678	CcSEcCtD
Ceftibuten—Pancytopenia—Cisplatin—germ cell cancer	0.00602	0.00674	CcSEcCtD
Ceftibuten—Haemoglobin—Ifosfamide—germ cell cancer	0.00591	0.00663	CcSEcCtD
Ceftibuten—Haemorrhage—Ifosfamide—germ cell cancer	0.00588	0.00659	CcSEcCtD
Ceftibuten—Chills—Dactinomycin—germ cell cancer	0.00576	0.00645	CcSEcCtD
Ceftibuten—Erythema multiforme—Ifosfamide—germ cell cancer	0.00556	0.00623	CcSEcCtD
Ceftibuten—Renal failure—Cisplatin—germ cell cancer	0.00555	0.00622	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—germ cell cancer	0.00554	0.00621	CcSEcCtD
Ceftibuten—Anorexia—Vinblastine—germ cell cancer	0.00552	0.00619	CcSEcCtD
Ceftibuten—Pancytopenia—Etoposide—germ cell cancer	0.00551	0.00618	CcSEcCtD
Ceftibuten—Neutropenia—Etoposide—germ cell cancer	0.00543	0.00608	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—germ cell cancer	0.00541	0.00607	CcSEcCtD
Ceftibuten—Chills—Ifosfamide—germ cell cancer	0.00528	0.00592	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—germ cell cancer	0.00523	0.00586	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—germ cell cancer	0.0052	0.00583	CcSEcCtD
Ceftibuten—Paraesthesia—Vinblastine—germ cell cancer	0.0052	0.00583	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00513	0.00575	CcSEcCtD
Ceftibuten—Renal failure—Etoposide—germ cell cancer	0.00509	0.0057	CcSEcCtD
Ceftibuten—Jaundice—Etoposide—germ cell cancer	0.00505	0.00565	CcSEcCtD
Ceftibuten—Decreased appetite—Vinblastine—germ cell cancer	0.00503	0.00564	CcSEcCtD
Ceftibuten—Constipation—Vinblastine—germ cell cancer	0.00495	0.00555	CcSEcCtD
Ceftibuten—Anaphylactic shock—Bleomycin—germ cell cancer	0.00489	0.00548	CcSEcCtD
Ceftibuten—Agranulocytosis—Etoposide—germ cell cancer	0.00483	0.00541	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00473	0.00531	CcSEcCtD
Ceftibuten—Agitation—Ifosfamide—germ cell cancer	0.00471	0.00527	CcSEcCtD
Ceftibuten—SLC15A2—retina—germ cell cancer	0.00467	0.0434	CbGeAlD
Ceftibuten—Anorexia—Bleomycin—germ cell cancer	0.00466	0.00522	CcSEcCtD
Ceftibuten—Abdominal pain—Vinblastine—germ cell cancer	0.00458	0.00513	CcSEcCtD
Ceftibuten—Convulsion—Ifosfamide—germ cell cancer	0.00444	0.00497	CcSEcCtD
Ceftibuten—Erythema multiforme—Etoposide—germ cell cancer	0.00439	0.00492	CcSEcCtD
Ceftibuten—Paraesthesia—Bleomycin—germ cell cancer	0.00439	0.00492	CcSEcCtD
Ceftibuten—Dyspnoea—Bleomycin—germ cell cancer	0.00436	0.00489	CcSEcCtD
Ceftibuten—Flatulence—Cisplatin—germ cell cancer	0.00435	0.00488	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—germ cell cancer	0.00435	0.00487	CcSEcCtD
Ceftibuten—SLC15A1—endocrine gland—germ cell cancer	0.00434	0.0403	CbGeAlD
Ceftibuten—SLC15A2—telencephalon—germ cell cancer	0.0043	0.0399	CbGeAlD
Ceftibuten—Hypersensitivity—Vinblastine—germ cell cancer	0.00427	0.00478	CcSEcCtD
Ceftibuten—Decreased appetite—Bleomycin—germ cell cancer	0.00425	0.00476	CcSEcCtD
Ceftibuten—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00418	0.00468	CcSEcCtD
Ceftibuten—Chills—Etoposide—germ cell cancer	0.00417	0.00467	CcSEcCtD
Ceftibuten—Asthenia—Vinblastine—germ cell cancer	0.00415	0.00466	CcSEcCtD
Ceftibuten—Anorexia—Ifosfamide—germ cell cancer	0.00398	0.00446	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—germ cell cancer	0.00396	0.00444	CcSEcCtD
Ceftibuten—Diarrhoea—Vinblastine—germ cell cancer	0.00396	0.00444	CcSEcCtD
Ceftibuten—Dysgeusia—Etoposide—germ cell cancer	0.00396	0.00444	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—germ cell cancer	0.00393	0.00441	CcSEcCtD
Ceftibuten—Urticaria—Bleomycin—germ cell cancer	0.00389	0.00435	CcSEcCtD
Ceftibuten—Body temperature increased—Bleomycin—germ cell cancer	0.00387	0.00433	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—germ cell cancer	0.00384	0.0043	CcSEcCtD
Ceftibuten—Dizziness—Vinblastine—germ cell cancer	0.00383	0.00429	CcSEcCtD
Ceftibuten—Convulsion—Cisplatin—germ cell cancer	0.00383	0.00429	CcSEcCtD
Ceftibuten—Paraesthesia—Ifosfamide—germ cell cancer	0.00375	0.00421	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00373	0.00418	CcSEcCtD
Ceftibuten—Dyspnoea—Ifosfamide—germ cell cancer	0.00373	0.00418	CcSEcCtD
Ceftibuten—Somnolence—Ifosfamide—germ cell cancer	0.00372	0.00416	CcSEcCtD
Ceftibuten—Vomiting—Vinblastine—germ cell cancer	0.00368	0.00413	CcSEcCtD
Ceftibuten—Decreased appetite—Ifosfamide—germ cell cancer	0.00363	0.00407	CcSEcCtD
Ceftibuten—Headache—Vinblastine—germ cell cancer	0.00363	0.00406	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00362	0.00406	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00361	0.00404	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—germ cell cancer	0.00361	0.00404	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—germ cell cancer	0.00361	0.00404	CcSEcCtD
Ceftibuten—Fatigue—Ifosfamide—germ cell cancer	0.0036	0.00404	CcSEcCtD
Ceftibuten—Anaphylactic shock—Cisplatin—germ cell cancer	0.0036	0.00404	CcSEcCtD
Ceftibuten—Hypersensitivity—Bleomycin—germ cell cancer	0.0036	0.00404	CcSEcCtD
Ceftibuten—Constipation—Ifosfamide—germ cell cancer	0.00357	0.00401	CcSEcCtD
Ceftibuten—Asthenia—Bleomycin—germ cell cancer	0.00351	0.00393	CcSEcCtD
Ceftibuten—Convulsion—Etoposide—germ cell cancer	0.0035	0.00393	CcSEcCtD
Ceftibuten—SLC15A2—pituitary gland—germ cell cancer	0.0035	0.0325	CbGeAlD
Ceftibuten—Pruritus—Bleomycin—germ cell cancer	0.00346	0.00388	CcSEcCtD
Ceftibuten—Nausea—Vinblastine—germ cell cancer	0.00344	0.00385	CcSEcCtD
Ceftibuten—Anorexia—Cisplatin—germ cell cancer	0.00343	0.00385	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00342	0.00383	CcSEcCtD
Ceftibuten—SLC15A2—medulla oblongata—germ cell cancer	0.00338	0.0314	CbGeAlD
Ceftibuten—Hypersensitivity—Dactinomycin—germ cell cancer	0.00336	0.00377	CcSEcCtD
Ceftibuten—Urticaria—Ifosfamide—germ cell cancer	0.00332	0.00372	CcSEcCtD
Ceftibuten—Abdominal pain—Ifosfamide—germ cell cancer	0.0033	0.0037	CcSEcCtD
Ceftibuten—Body temperature increased—Ifosfamide—germ cell cancer	0.0033	0.0037	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—germ cell cancer	0.0033	0.0037	CcSEcCtD
Ceftibuten—Anaphylactic shock—Etoposide—germ cell cancer	0.0033	0.0037	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—germ cell cancer	0.00327	0.00367	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—germ cell cancer	0.00325	0.00364	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—germ cell cancer	0.00325	0.00364	CcSEcCtD
Ceftibuten—Paraesthesia—Cisplatin—germ cell cancer	0.00324	0.00363	CcSEcCtD
Ceftibuten—Dyspnoea—Cisplatin—germ cell cancer	0.00321	0.0036	CcSEcCtD
Ceftibuten—Anorexia—Etoposide—germ cell cancer	0.00315	0.00353	CcSEcCtD
Ceftibuten—Decreased appetite—Cisplatin—germ cell cancer	0.00313	0.00351	CcSEcCtD
Ceftibuten—SLC15A2—adrenal gland—germ cell cancer	0.00313	0.0291	CbGeAlD
Ceftibuten—Diarrhoea—Dactinomycin—germ cell cancer	0.00312	0.0035	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00311	0.00349	CcSEcCtD
Ceftibuten—Vomiting—Bleomycin—germ cell cancer	0.00311	0.00348	CcSEcCtD
Ceftibuten—SLC15A2—midbrain—germ cell cancer	0.00309	0.0287	CbGeAlD
Ceftibuten—Rash—Bleomycin—germ cell cancer	0.00308	0.00346	CcSEcCtD
Ceftibuten—Dermatitis—Bleomycin—germ cell cancer	0.00308	0.00345	CcSEcCtD
Ceftibuten—Hypersensitivity—Ifosfamide—germ cell cancer	0.00308	0.00345	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00307	0.00344	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—germ cell cancer	0.00305	0.00342	CcSEcCtD
Ceftibuten—SLC15A2—spinal cord—germ cell cancer	0.00301	0.028	CbGeAlD
Ceftibuten—Asthenia—Ifosfamide—germ cell cancer	0.003	0.00336	CcSEcCtD
Ceftibuten—Paraesthesia—Etoposide—germ cell cancer	0.00296	0.00332	CcSEcCtD
Ceftibuten—Pruritus—Ifosfamide—germ cell cancer	0.00296	0.00331	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—germ cell cancer	0.00296	0.00331	CcSEcCtD
Ceftibuten—Dyspnoea—Etoposide—germ cell cancer	0.00294	0.0033	CcSEcCtD
Ceftibuten—Somnolence—Etoposide—germ cell cancer	0.00293	0.00329	CcSEcCtD
Ceftibuten—SLC15A2—female gonad—germ cell cancer	0.00292	0.0271	CbGeAlD
Ceftibuten—Nausea—Bleomycin—germ cell cancer	0.0029	0.00326	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—germ cell cancer	0.0029	0.00325	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—germ cell cancer	0.00289	0.00324	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—germ cell cancer	0.00288	0.00322	CcSEcCtD
Ceftibuten—Decreased appetite—Etoposide—germ cell cancer	0.00287	0.00322	CcSEcCtD
Ceftibuten—Diarrhoea—Ifosfamide—germ cell cancer	0.00286	0.0032	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00285	0.00319	CcSEcCtD
Ceftibuten—Body temperature increased—Cisplatin—germ cell cancer	0.00285	0.00319	CcSEcCtD
Ceftibuten—Fatigue—Etoposide—germ cell cancer	0.00285	0.00319	CcSEcCtD
Ceftibuten—Constipation—Etoposide—germ cell cancer	0.00282	0.00316	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—germ cell cancer	0.0028	0.00313	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—germ cell cancer	0.00278	0.00312	CcSEcCtD
Ceftibuten—Dizziness—Ifosfamide—germ cell cancer	0.00276	0.0031	CcSEcCtD
Ceftibuten—SLC15A2—endocrine gland—germ cell cancer	0.00271	0.0252	CbGeAlD
Ceftibuten—Nausea—Dactinomycin—germ cell cancer	0.00271	0.00304	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Etoposide—germ cell cancer	0.0027	0.00302	CcSEcCtD
Ceftibuten—SLC15A2—head—germ cell cancer	0.00268	0.0249	CbGeAlD
Ceftibuten—Vomiting—Ifosfamide—germ cell cancer	0.00266	0.00298	CcSEcCtD
Ceftibuten—Hypersensitivity—Cisplatin—germ cell cancer	0.00265	0.00297	CcSEcCtD
Ceftibuten—Rash—Ifosfamide—germ cell cancer	0.00264	0.00295	CcSEcCtD
Ceftibuten—Dermatitis—Ifosfamide—germ cell cancer	0.00263	0.00295	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—germ cell cancer	0.00263	0.00295	CcSEcCtD
Ceftibuten—Urticaria—Etoposide—germ cell cancer	0.00262	0.00294	CcSEcCtD
Ceftibuten—Abdominal pain—Etoposide—germ cell cancer	0.00261	0.00292	CcSEcCtD
Ceftibuten—Body temperature increased—Etoposide—germ cell cancer	0.00261	0.00292	CcSEcCtD
Ceftibuten—SLC15A2—testis—germ cell cancer	0.00259	0.024	CbGeAlD
Ceftibuten—Asthenia—Cisplatin—germ cell cancer	0.00259	0.0029	CcSEcCtD
Ceftibuten—Chills—Methotrexate—germ cell cancer	0.0025	0.0028	CcSEcCtD
Ceftibuten—Nausea—Ifosfamide—germ cell cancer	0.00248	0.00278	CcSEcCtD
Ceftibuten—Diarrhoea—Cisplatin—germ cell cancer	0.00247	0.00276	CcSEcCtD
Ceftibuten—Hypersensitivity—Etoposide—germ cell cancer	0.00243	0.00273	CcSEcCtD
Ceftibuten—SLC15A2—cerebellum—germ cell cancer	0.00239	0.0222	CbGeAlD
Ceftibuten—Dysgeusia—Methotrexate—germ cell cancer	0.00237	0.00266	CcSEcCtD
Ceftibuten—Asthenia—Etoposide—germ cell cancer	0.00237	0.00265	CcSEcCtD
Ceftibuten—Pruritus—Etoposide—germ cell cancer	0.00234	0.00262	CcSEcCtD
Ceftibuten—Vomiting—Cisplatin—germ cell cancer	0.00229	0.00257	CcSEcCtD
Ceftibuten—Rash—Cisplatin—germ cell cancer	0.00227	0.00255	CcSEcCtD
Ceftibuten—Dermatitis—Cisplatin—germ cell cancer	0.00227	0.00254	CcSEcCtD
Ceftibuten—Diarrhoea—Etoposide—germ cell cancer	0.00226	0.00253	CcSEcCtD
Ceftibuten—Dizziness—Etoposide—germ cell cancer	0.00218	0.00245	CcSEcCtD
Ceftibuten—Nausea—Cisplatin—germ cell cancer	0.00214	0.0024	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—germ cell cancer	0.0021	0.00235	CcSEcCtD
Ceftibuten—Vomiting—Etoposide—germ cell cancer	0.0021	0.00235	CcSEcCtD
Ceftibuten—Rash—Etoposide—germ cell cancer	0.00208	0.00233	CcSEcCtD
Ceftibuten—Dermatitis—Etoposide—germ cell cancer	0.00208	0.00233	CcSEcCtD
Ceftibuten—Headache—Etoposide—germ cell cancer	0.00207	0.00232	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—germ cell cancer	0.00198	0.00222	CcSEcCtD
Ceftibuten—Nausea—Etoposide—germ cell cancer	0.00196	0.0022	CcSEcCtD
Ceftibuten—SLC15A2—brain—germ cell cancer	0.00194	0.018	CbGeAlD
Ceftibuten—Anorexia—Methotrexate—germ cell cancer	0.00188	0.00211	CcSEcCtD
Ceftibuten—SLC15A2—lymph node—germ cell cancer	0.00187	0.0174	CbGeAlD
Ceftibuten—Insomnia—Methotrexate—germ cell cancer	0.00179	0.002	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—germ cell cancer	0.00178	0.00199	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—germ cell cancer	0.00176	0.00198	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—germ cell cancer	0.00176	0.00197	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—germ cell cancer	0.00174	0.00195	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—germ cell cancer	0.00172	0.00193	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00171	0.00191	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—germ cell cancer	0.0017	0.00191	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00162	0.00181	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—germ cell cancer	0.00157	0.00176	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—germ cell cancer	0.00156	0.00175	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—germ cell cancer	0.00156	0.00175	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—germ cell cancer	0.00146	0.00163	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—germ cell cancer	0.00142	0.00159	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—germ cell cancer	0.0014	0.00157	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—germ cell cancer	0.00135	0.00152	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—germ cell cancer	0.00131	0.00147	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—germ cell cancer	0.00126	0.00141	CcSEcCtD
Ceftibuten—Rash—Methotrexate—germ cell cancer	0.00125	0.0014	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—germ cell cancer	0.00125	0.0014	CcSEcCtD
Ceftibuten—Headache—Methotrexate—germ cell cancer	0.00124	0.00139	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—germ cell cancer	0.00117	0.00132	CcSEcCtD
